&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-27, 19:30

VCI Global Announces Termination of Its At-the-Market Offering Program
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-16, 17:05

Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-03, 18:00

Colliers to acquire leading Western Australian engineering firm
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-27, 19:09

VCI Global CEO Increases Shareholding by 15.27%, Expresses Strong Confidence in Company’s Growth
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-22, 11:00

Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-08-13, 07:00

Acronis Expands Presence in New Zealand to Meet Growing Demand for Natively Integrated Cybersecurity Solutions
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-24, 06:01

Policymakers should recognise #SelfCareIsHealthcare in campaign bid to address global health challenges
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-10, 07:00

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal

Dora Legere

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-07-09, 07:00

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound
Dora Legere

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-06-28, 19:08

VCI Global Announces Secondary Listing on the Frankfurt Stock Exchange, Expanding its Market Reach
Dora Legere

Popular Posts